Log in to your account:
Goldman Sachs Downgrades Biogen (BIIB) to Neutral
March 21, 2019 10:33 AM
Goldman Sachs analyst Terence Flynn downgraded Biogen (NASDAQ: BIIB) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Biogen (BIIB) PT Lowered to $300 at H.C. Wainwright
March 25, 2019 7:49 AM